Polyflex 493-07 Endocardial Implantable Pac-Lead
by Intermedics, Inc. 510(k)
Active
510(k) K854071
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK854071 | Date4 Dec 1985 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Recalls
No FDA recalls on record, checked 22 Oct 2026.
Specification
- 510(k) Number
- FDA Product Code
- DTB
- Device Class
- Class III
- Regulation
- 21 CFR Part 870.3680
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The Polyflex 493-07 is a Permanent Pacemaker Electrode, designed for endocardial implantation to deliver pacing stimuli to the heart. This device is intended for use in patients requiring cardiac pacing, providing electrical stimulation to regulate heart rhythm through direct contact with the endocardium.
This lead is supplied sterile and intended for single-use implantation, adhering to FDA 510(k) clearance under the Cardiovascular advisory committee. It is classified as a Class III medical device under regulation 870.3680, requiring strict adherence to implantation protocols in sterile operating environments. The device is compatible with MRI environments as specified in its design and labeling.
Other devices from Intermedics, Inc.
Questions
AI-generated answers, 18 Sep 2026
What is the Polyflex 493-07 Endocardial Implantable Pac-Lead used for in clinical practice?
The Polyflex 493-07 is designed for endocardial implantation to deliver pacing stimuli directly to the heart, helping regulate abnormal heart rhythms in patients requiring cardiac pacing. It provides electrical stimulation to maintain proper heart function by contacting the inner lining of the heart chambers.
Is this pacemaker lead intended for reuse, or is it meant to be used only once?
This device is sterile upon supply and intended for single-use only. Due to its classification as a Class III medical device, it must be implanted in a sterile operating environment, which aligns with its non-reusable design to ensure patient safety and infection control.
How is the Polyflex 493-07 compatible with MRI environments, and what does that mean for patients?
The Polyflex 493-07 is specifically designed to be MRI-compatible, meaning it can be safely used in magnetic resonance imaging environments under the conditions outlined in its labeling. This allows patients with this pacemaker lead to undergo MRI scans when clinically necessary, provided they follow the manufacturer’s MRI safety guidelines.
What regulatory pathway was followed for FDA clearance of this pacemaker lead?
The Polyflex 493-07 received FDA 510(k) clearance through the Cardiovascular (CV) Advisory Committee under the Traditional 510(k) review pathway. It was determined to be substantially equivalent to a predicate device, meeting strict regulatory requirements for Class III permanent pacemaker electrodes (regulation 870.3680).